Your email has been successfully added to our mailing list.

×
0.0270270270270271 0.00675675675675676 -0.0270270270270269 -0.0135135135135135 -0.135135135135135 -0.155810810810811 -0.283783783783784 -0.334189189189189
Stock impact report

BioPharmX up 60% premarket on positive BPX-04 data [Seeking Alpha]

BIOPHARMX CORP (BPMX) 
NASDAQ:AMEX Investor Relations: biopharmx.com
Company Research Source: Seeking Alpha
BioPharmX up 60% premarket on positive BPX-04 data Nano cao BioPharmX (NYSEMKT: BPMX 60% positive results PRISM papulopustular rosacea The study met the primary and secondary endpoints, demonstrating a statistically significant improvement in the number of facial inflammatory lesions and a two-grade improvement to clear or almost clear skin from baseline to week 12. A Phase 3 study is next up. Show less Read more
Impact Snapshot
Event Time:
BPMX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BPMX alerts
Opt-in for
BPMX alerts

from News Quantified
Opt-in for
BPMX alerts

from News Quantified